Phenylalanine as a biomarker of disease in animals: Current evidence and future perspectives

Phenylalanine (Phe), an essential aromatic amino acid, is emerging as a potential biomarker of metabolic and health status in animals. Altered Phe concentrations reflect changes in metabolic, inflammatory, and disease processes. In companion animals, shifts in serum or biofluid Phe have been linked to hepatopathies, inflammatory enteropathies, and neoplastic conditions. In livestock, variations in milk or serum Phe accompany mastitis, metabolic stress, lameness, and other production-related disorders. Evidence for cats, horses, poultry, and aquaculture species remains limited. Interpretation is complicated by analytical variability, small sample sizes, and confounding factors such as diet, stress, and microbiome composition. Non-invasive sampling of milk, urine, saliva, and breath, shows promise for Phe monitoring across animal species. Advances in multi-omics, particularly metabolomics, proteomics, and microbiome analyses, can clarify mechanisms and support development of composite biomarker panels. This review evaluates current evidence on Phe as a biomarker across species, highlights gaps in research coverage and methodology, and outlines priorities for future work. Expanding studies to underrepresented species, standardizing measurement protocols, and conducting longitudinal research. Addressing these priorities is essential to establish Phe as a robust biomarker, for veterinary diagnostics, health monitoring, and the optimization of animal welfare and production systems. SHORT SUMMARY: This review looks at phenylalanine (Phe), an amino acid, as a possible health indicator in animals. Changes in Phe levels may show problems with metabolism, inflammation, or disease. Evidence is strongest for dogs and dairy cows, but limited for cats, horses, poultry, and fish. Results vary due to measurement methods and other factors. Future studies should standardize testing, include more species, and combine methods to improve Phe's usefulness in monitoring animal health.

Authors

Institutions

Publication Details

Journal
Research in Veterinary Science
Published
2026-01-22
DOI
https://doi.org/10.1016/j.rvsc.2026.106066
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phenylalanine as a biomarker of disease in animals: Current evidence and future perspectives

JD METTAM, Jully Gogoi-Tiwari, Nauman Zaheer Ghumman, Bao-Tao Liu et al.
Research in Veterinary Science
Metabolomics and Mass Spectrometry Studies
article

Phenylalanine as a biomarker of disease in animals: Current evidence and future perspectives

JD METTAM, Jully Gogoi-Tiwari, Nauman Zaheer Ghumman, Bao-Tao Liu, Henry Annandale
article en

Abstract

Phenylalanine (Phe), an essential aromatic amino acid, is emerging as a potential biomarker of metabolic and health status in animals. Altered Phe concentrations reflect changes in metabolic, inflammatory, and disease processes. In companion animals, shifts in serum or biofluid Phe have been linked to hepatopathies, inflammatory enteropathies, and neoplastic conditions. In livestock, variations in milk or serum Phe accompany mastitis, metabolic stress, lameness, and other production-related disorders. Evidence for cats, horses, poultry, and aquaculture species remains limited. Interpretation is complicated by analytical variability, small sample sizes, and confounding factors such as diet, stress, and microbiome composition. Non-invasive sampling of milk, urine, saliva, and breath, shows promise for Phe monitoring across animal species. Advances in multi-omics, particularly metabolomics, proteomics, and microbiome analyses, can clarify mechanisms and support development of composite biomarker panels. This review evaluates current evidence on Phe as a biomarker across species, highlights gaps in research coverage and methodology, and outlines priorities for future work. Expanding studies to underrepresented species, standardizing measurement protocols, and conducting longitudinal research. Addressing these priorities is essential to establish Phe as a robust biomarker, for veterinary diagnostics, health monitoring, and the optimization of animal welfare and production systems. SHORT SUMMARY: This review looks at phenylalanine (Phe), an amino acid, as a possible health indicator in animals. Changes in Phe levels may show problems with metabolism, inflammation, or disease. Evidence is strongest for dogs and dairy cows, but limited for cats, horses, poultry, and fish. Results vary due to measurement methods and other factors. Future studies should standardize testing, include more species, and combine methods to improve Phe's usefulness in monitoring animal health.

Research in Veterinary ScienceVol. 202
Qingdao Agricultural University (CN), Murdoch University (AU)
Openalex Percentile: Top 82%
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.